Basaglar 100IU/ml Kwikpen: A Comprehensive Guide
Basaglar 100IU/ml Kwikpen is a prescription medicine manufactured by Cipla Ltd. It contains the active ingredient Insulin Glargine (100IU/ml) and is available in a pre-filled pen format with 3 ml per pen. This insulin analog belongs to the therapeutic class of anti-diabetic medications and falls under the chemical class of insulin analogues. Basaglar is specifically classified as a long-acting insulin analogue.
Uses of Basaglar
Basaglar is primarily used for the management of diabetes mellitus, including both Type 1 and Type 2 diabetes. It helps regulate blood glucose levels in patients with diabetes and is often prescribed as part of a comprehensive treatment plan that may include lifestyle modifications and other medications.
Price and Dosage
The Maximum Retail Price (MRP) of Basaglar 100IU/ml Kwikpen is ₹1028. The dosage of Basaglar can vary depending on individual factors such as age, weight, and severity of diabetes. It is crucial to follow your healthcare provider’s instructions regarding the correct dosage and administration schedule.
Benefits of Basaglar
Basaglar offers several benefits for individuals with diabetes, including effective control of blood glucose levels, reduction of diabetic complications, and improvement in overall quality of life. By maintaining stable insulin levels, Basaglar helps prevent hyperglycemia and its associated health risks.
Side Effects of Basaglar
Like any medication, Basaglar may cause side effects in some patients. Common side effects of Basaglar include:
- Hypoglycemia (low blood glucose levels)
- Injection site allergic reactions
- Lipodystrophy (skin thickening or pits at the injection site)
It is important to monitor for these side effects and consult with your healthcare provider if you experience any concerning symptoms.
Active Ingredients and Pharmacological Properties
The active ingredient in Basaglar, Insulin Glargine, is a long-acting insulin analogue that mimics the natural insulin produced by the body. Insulin Glargine helps regulate glucose metabolism and promotes the uptake of glucose by cells, thereby lowering blood sugar levels.
Indications and Contraindications
Basaglar is indicated for the treatment of diabetes mellitus and should be used under the supervision of a healthcare professional. It is contraindicated in patients with hypersensitivity to insulin glargine or any other components of the product. Patients with certain medical conditions or allergies should consult their doctor before using Basaglar.
Drug Interactions
Basaglar may interact with other medications, supplements, or substances, potentially affecting its efficacy or causing adverse reactions. It is essential to inform your healthcare provider about all the medications you are taking, including prescription, over-the-counter, and herbal products, to avoid any harmful drug interactions.
Patient Counseling on Basaglar
Patients using Basaglar should receive proper counseling from their healthcare providers regarding its correct usage, storage, and monitoring of blood glucose levels. It is important to follow the prescribed dose and administration instructions carefully to achieve optimal treatment outcomes.
Clinical Evidence and Research Studies
Several clinical studies and research trials have demonstrated the effectiveness and safety of Basaglar in the management of diabetes mellitus. These studies have highlighted the consistent glucose-lowering effects of Basaglar and its role in reducing the risk of diabetic complications.
Frequently Asked Questions (FAQs) about Basaglar
Q: Is Basaglar the same as other insulin glargine products?
A: Basaglar contains insulin glargine, the same active ingredient found in other insulin glargine products. However, Basaglar may have slight formulation differences that make it a distinct product.
Q: Can Basaglar be used in children with diabetes?
A: Basaglar is approved for use in adults with diabetes. Pediatric use should be discussed with a healthcare provider, as dosing and safety considerations may differ for children.
Q: How should Basaglar be stored?
A: Basaglar should be stored in the refrigerator at a temperature between 36°F to 46°F (2°C to 8°C). Once in use, it can be kept at room temperature not exceeding 86°F (30°C) for up to 28 days.
Q: What should I do if I miss a dose of Basaglar?
A: If you miss a dose of Basaglar, take it as soon as you remember, but do not double the dose to make up for a missed one. Consult your healthcare provider for specific advice on managing missed doses.
Remember, the information provided here is for educational purposes only and should not be construed as medical advice. Consult your healthcare provider for personalized recommendations and guidance on using Basaglar for your condition.
MRP:
₹1028
Manufacturer:
Cipla Ltd
Salt:
Insulin Glargine (100IU/ml),
How to UseBasaglar 100IU/ml Kwikpen:
Your doctor or nurse will guide you how to use this medicine.
Side Effects of Basaglar 100IU/ml Kwikpen:
Hypoglycemia (low blood glucose level),Injection site allergic reaction,Lipodystrophy (skin thickening or pits at the injection site),
Alternate Medicines for Basaglar 100IU/ml Kwikpen:
Prescription Required Status:
Prescription Required
Type of Selection:
3 ml in 1 pre-filled pen
Chemical Class:
Insulin analogue
Habit Forming:
No
Therapeutic Class:
ANTI DIABETIC
Action Class:
Insulin analogues- long acting
. Please note, this information is for educational purposes only and not intended as medical advice.
